AI
IONS icon

Axiom Investors’s Ionis Pharmaceuticals IONS Stock Holding History

Axiom Investors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-34,877
Closed -$2.22M – 140
2015
Q1 		$2.22M Buy
34,877
+8,547
+32% +$580K 0.06% 108
2014
Q4 		$1.63M Buy
+26,330
New +$1.3M 0.04% 124

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Axiom Investors's IONS Position: Q2 2015 in Review

Axiom Investors sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 34,877 shares — an estimated $2.22M sold.

Axiom Investors first reported a position in IONS in Q4 2014 and held it in 2 quarters. The position peaked at $2.22M in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

  • Axiom Investors reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Axiom Investors sold 34,877 Ionis Pharmaceuticals shares in Q2 2015, an estimated $2.22M.
  • Axiom Investors first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Axiom Investors's Ionis Pharmaceuticals position peaked at $2.22M in Q1 2015.
  • 353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Axiom Investors's 13F filing for Q2 2015, filed 13 Aug 2015.